 | Vol. 10.09 – 10 March, 2021 |
| |
|
|
| The authors identified E26 transformation-specific homologous factor as a key molecule in decreasing the sensitivity of pancreatic cancer cells to cancer stem cells’ niche stimulus. [Gut] |
|  |
|
|
PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| Human embryonic stem cells were induced to differentiate into hepatocytes along hepatic lineages to mimic liver development in vitro. [Nature Communications] |
|
|
|
| Investigators revealed that the phosphorylation state of the HV H2A.X (γH2A.X) regulated self-renewal and differentiation of human pluripotent stem cells and leukemic progenitors. [Cell Reports] |
|
|
|
| Innovated AR-independent therapy might alleviate enzalutamide resistance and prevent production of adverse side effects. Scientists identified that yes-associated protein 1 (YAP1) was overexpressed in enzalutamide-resistant cells. [Oncogene] |
|
|
|
| Researchers demonstrated that aurora-A kinase is required to mediate TGF-β-induced expression of the SNAI1 gene, enrichment of ALDH1high breast tumor-initiating cells, self-renewal capacity, and chemoresistance in TNBC experimental models. [Oncogene] |
|
|
|
| A distinct heterogeneity in GASC1 levels was observed among hepatocellular carcinoma cell populations, predicting their inherent high or low tumor-initiating capacity. [Cell Death & Disease] |
|
|
|
| Scientists characterized and identify a subpopulation of CD133+ cancer stem-like cells derived from SK-UT-1 cell line. [Cancer Cell International] |
|
|
|
| Investigators established conditionally immortalised myeloid progenitor cell lines co-expressing constitutive Hoxa9.EGFP and inducible Meis1.dTomato to study growth behavior, immunophenotype and morphology under different cytokine/microenvironmental conditions ex vivo upon doxycycline induction or removal. [Scientific Reports] |
|
|
|
| CSC capacities were evaluated regarding capacity to form spheres, expression of stem cell markers and the presence of ALDHhigh cells. [BMC Cancer] |
|  |
|
|
|
| Scientists discuss the metabolic properties of leukemia stem cells and how targeting energy metabolism may provide more effective therapeutic regimens for leukemia patients. [Cell Stem Cell] |
|
|
|
| Investigators summarize the molecular mechanism by which CSCs-derived extracellular vesicles in tumor progression. [Signal Transduction and Targeted Therapy] |
|
|
|
| The authors review a wide range of both immunocapture and label free circulating tumor cell enrichment technologies, summarising the most significant advantages and disadvantages of each. [Cancers] |
|
|
|
|
| OncoSynergy, Inc. announced that the first patient was treated in the company’s First-in-Human Phase I clinical trial evaluating OS2966 for the treatment of recurrent glioblastoma at Moffitt Cancer Center in Tampa, Florida. OS2966 is a first-in-class immunotherapy, and the first ever anti-CD29 therapeutic to reach human trials. [OncoSynergy, Inc. (PR Newswire. LLC)] |
|
|
|
| Kite, a Gilead Company announced that the FDA has granted accelerated approval to Yescarta® for the treatment of adult patients with relapsed or refractory follicular lymphoma after two or more lines of systemic therapy. [Gilead Sciences, Inc.] |
|
|
|
| US Congressman Donald Norcross announced that the Coriell Institute for Medical Research, located in Camden, has been awarded a $408,617 grant from the National Cancer Institute. This grant will go towards a research project aimed at exploring drug resistance in patients with acute myeloid leukemia. [Donald Norcross] |
|
|
|
|
|
|
|
| The University of British Columbia – Vancouver, British Columbia, Canada |
|
|
|
| UC San Francisco – Location |
|
|
|
| Cancer Research Center of Lyon – Lyon, France |
|
|
|
| Dana-Farber Cancer Institute – Boston, Massachusetts, United States |
|
|
|
| University of Notre Dame – Notre Dame, Indiana, United States |
|
|
|
|